One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Psoriasis: Rediscovering the meaning of the name
Riccardo Balestri, Michela Magnano, Giulia Rech
doi : 10.1111/jdv.18950
Skin microbiome in atopic dermatitis: New insights from clinical trials
Florian Rieder, Pranab K. Mukherjee
doi : 10.1111/jdv.18991
Pioneers in Dermatology and Venereology: An Interview with Professor Alain Taieb
Alain Taieb
doi : 10.1111/jdv.18971
Infantile haemangioma in a 17th-century painting
Nicolas Kluger, Pierre Vabres
doi : 10.1111/jdv.18833
Determining the clinical applicability of machine learning models through assessment of reporting across skin phototypes and rarer skin cancer types: A systematic review
Lloyd Steele, Xiang Li Tan, Bayanne Olabi, Jing Mia Gao, Reiko J. Tanaka, Hywel C. Williams
doi : 10.1111/jdv.18814
Machine learning (ML) models for skin cancer recognition may have variable performance across different skin phototypes and skin cancer types. Overall performance metrics alone are insufficient to detect poor subgroup performance. We aimed (1) to assess whether studies of ML models reported results separately for different skin phototypes and rarer skin cancers, and (2) to graphically represent the skin cancer training datasets used by current ML models.
Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase-4 inhibitors
Aditya K. Gupta, Tong Wang, Shruthi Polla Ravi, Mary A. Bamimore, Vincent Piguet, Antonella Tosti
doi : 10.1111/jdv.18810
Management options for moderate-to-severe alopecia areata (AA) are limited owing to a lack of safe and effective treatments suitable for long-term use. However, newer agents have the potential to induce and maintain hair regrowth in patients with a better side-effects profile compared to systemic steroids or conventional systemic agents.
Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey
Pietro Quaglino, Julia Scarisbrick, Gabriele Roccuzzo, Alejandra Abeldano, Maxime Battistella, Chris McCormack, Richard Cowan, Antonio Cozzio, Jade Cury-Martins, Paula Enz, Larisa Geskin, Emmanuella Guenova, Youn H. Kim, Robert Knobler, Ivan V. Litvinov, Tomomitsu Miyagaki, Montserrat Molgo, Jan Nicolay, Evangelina Papadavid, Lauren Pinter-Brown, Ramon Pujol Vallverdu, Christiane Querfeld, Pablo Ortiz-Romero, Rudolf Stadler, Maarten H. Vermeer, Martine Bagot, Emmilia Hodak
doi : 10.1111/jdv.18852
Consensus about the definition and classification of ‘plaque’ in mycosis fungoides is lacking.
Brodalumab in plaque psoriasis: Real-world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks
Natalia Rompoti, Maria Politou, Irene Stefanaki, Charitomeni Vavouli, Marina Papoutsaki, Afroditi Neofotistou, Dimitrios Rigopoulos, Alexander Stratigos, Electra Nicolaidou
doi : 10.1111/jdv.18825
Brodalumab, a fully human IgG2k antibody blocking the receptor of IL17, is characterized by a rapid onset of action with high skin clearance rates in clinical trials. Since setting PASI90/100 or absolute PASI ≤ 3 as treatment goals have become attainable, evaluating the effectiveness and safety profile of biologic agents, such as brodalumab, in a real-world setting is essential.
Blocking interleukin-17 in psoriasis: Real-world experience from the PsoPlus cohort
Lisa Schots, Rani Soenen, Brigitte Blanquart, Debby Thomas, Jo Lambert
doi : 10.1111/jdv.18827
Real-world studies on the use of biologics in psoriasis (Pso) are increasing, but still scarce. Trough concentrations (Cts) of interleukin-17 inhibitors (IL-17i) seem promising for clinical decision-making, but their value in daily practice has yet to be proven.
Oral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tablets
Richard B. Warren, Bruce Strober, Jonathan I. Silverberg, Emma Guttman, Philippe Andres, Jakob Felding, Deniz Tutkunkardas, Kim Kjøller, Morten O. A. Sommer, Lars E. French
doi : 10.1111/jdv.18812
Orismilast is a high-potency phosphodiesterase 4 (PDE4) inhibitor with enhanced selectivity for the PDE4B and PDE4D subtypes.
Pharmacology of orismilast, a potent and selective PDE4 inhibitor
Jonathan I. Silverberg, Lars E. French, Richard B. Warren, Bruce Strober, Kim Kjøller, Morten O. A. Sommer, Philippe Andres, Jakob Felding, Anne Weiss, Deniz Tutkunkardas, Tine Skak-Nielsen, Emma Guttman
doi : 10.1111/jdv.18818
There remains an unmet need for oral medications that are safe and efficacious for long-term management of chronic inflammatory skin diseases (CISD). Inhibition of phosphodiesterase 4 (PDE4) can modulate a broad range of pro-inflammatory cytokines that play a major role in CISD pathogenesis. Orismilast is a second generation PDE4 inhibitor in clinical development for CISD treatment.
Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study
Alexander A. Navarini, Jörg C. Prinz, Akimichi Morita, Tsen-Fang Tsai, Manuelle-Anne Viguier, Ling Li, Christian Thoma, Mogana Sivalingam, Mark G. Lebwohl
doi : 10.1111/jdv.18820
Generalized pustular psoriasis (GPP) is a rare inflammatory skin disease with a considerable clinical burden. In the Effisayilâ„¢ 1 study, spesolimab, an anti-interleukin-36 receptor monoclonal antibody, demonstrated efficacy in treating GPP flares.
Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management
LluÃs Puig, Siew Eng Choon, Alice B. Gottlieb, Slaheddine Marrakchi, Jörg C. Prinz, Ricardo Romiti, Yayoi Tada, Dorothea von Bredow, Melinda Gooderham
doi : 10.1111/jdv.18851
Generalized pustular psoriasis (GPP) is a rare and highly heterogeneous skin disease, characterized by flares of neutrophilic pustules and erythema. As a rare disease with few clinical studies and no standardized management approaches, there is a paucity of knowledge regarding GPP.
Management and treatment outcome of DRESS patients in Europe: An international multicentre retrospective study of 141 cases
Khalaf Kridin, Marie-Charlotte Brüggen, Sarah Walsh, Benoit Bensaid, Annamari Ranki, Eva Oppel, Damian Meyersburg, Ser-Ling Chua, Corsin Seeli, Heidi Sandberg, Lars E. French, Artem Vorobyev, Saskia Ingen-Housz-Oro
doi : 10.1111/jdv.18808
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but potentially fatal drug hypersensitivity reaction.
Prevalence and associations of fatigue in childhood atopic dermatitis: A cross-sectional study
Stephanie M. Rangel, Theodore Kim, Anjani Sheth, Alli Blumstein, Jin-Shei Lai, David Cella, Amy S. Paller, Jonathan I. Silverberg
doi : 10.1111/jdv.18819
Fatigue is a symptom that can negatively impact patients' quality of life. However, the relationship of AD with fatigue has not been fully studied, especially in children.
Skin microbiome and its association with host cofactors in determining atopic dermatitis severity
Luise Rauer, Matthias Reiger, Madhumita Bhattacharyya, Patrick M. Brunner, James G. Krueger, Emma Guttman-Yassky, Claudia Traidl-Hoffmann, Avidan U. Neumann
doi : 10.1111/jdv.18776
Atopic dermatitis (AD) is a heterogeneous, chronic inflammatory skin disease linked to skin microbiome dysbiosis with reduced bacterial diversity and elevated relative abundance of Staphylococcus aureus (S. aureus).
Wako β-D-glucan assay can be used to measure serum β-D-glucan in Sudanese patients to aid with diagnosis of eumycetoma caused by Madurella mycetomatis
Bertrand Nyuykonge, Emmanuel Siddig, Najwa A. Mhmoud, Sahar Bakhiet, Eduard Zijlstra, Annelies Verbon, Ahmed H. Fahal, Wendy W. J. van de Sande
doi : 10.1111/jdv.18642
Eumycetoma is a neglected tropical infection of the subcutaneous tissue commonly caused by the fungus Madurella mycetomatis. Previously, we demonstrated that β-D-glucan was present in the serum of eumycetoma patients.
Characteristics of pruritus in various clinical variants of psoriasis: Final report of the binational, multicentre, cross-sectional study
Kamila Jaworecka, Dominika Kwiatkowska, Luiza Marek-Józefowicz, Funda Tamer, Aleksandra Stefaniak, Magdalena Szczegielniak, Joanna Chojnacka-Purpurowicz, Ayla Gulekon, Jacek C. Szepietowski, Joanna Narbutt, Agnieszka Owczarczyk-Saczonek, Adam Reich
doi : 10.1111/jdv.18850
Pruritus, which is the most frequent subjective symptom of psoriasis, may cause significant discomfort, embarrassment and even interfere with patients normal daily activities. However, the perception of itch in various psoriasis subtypes remains unknown.
GBP5 exacerbates rosacea-like skin inflammation by skewing macrophage polarization towards M1 phenotype through the NF-κB signalling pathway
Lei Zhou, Han Zhao, He Zhao, Xin Meng, Zhixiang Zhao, Hongfu Xie, Ji Li, Yan Tang, Yiya Zhang
doi : 10.1111/jdv.18725
Rosacea is a chronic inflammatory skin disease with increased macrophage infiltration. However, the molecular mechanism remains unclear.
Atrophic papulosis (Köhlmeier–Degos disease) in children and adolescents�A cross–sectional study and literature review
Christos C. Zouboulis, Katarzyna P. Kaleta, Elżbieta Broniatowska, Vaiva JarienÄ—, Georgios Nikolakis
doi : 10.1111/jdv.18844
Atrophic papulosis (Köhlmeier–Degos disease, Degos disease) is a rare thrombo-obliterative microangiopathy of unknown pathogenesis. It usually affects people between the ages of 20 and 50. However, it can occur at any age. The condition is considered uncommon in children.
Acral lamellar ichthyosis with amino acid substitution in the C-terminus of keratin 2
Leonie Frommherz, Katalin Komlosi, Charlotte Hewel, Julia Kopp, Malin Dewenter, Andreas Zimmer, Oliver Bartsch, Matthias Linke, Kristin Technau-Hafsi, Susanne Gerber, Judith Fischer, Cristina Has
doi : 10.1111/jdv.18719
Most cases of hereditary ichthyoses present with generalized scaling and skin dryness. However, in some cases skin involvement is restricted to particular body regions as in acral lamellar ichthyosis.
Long-term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial
Rolf-Markus Szeimies, Christoph Abels, Ana Kilic, Hubert Reich, Birgit Berger, Erik Schulze zur Wiesche, Katharina Schramm, Leonie Litzka, Susanne Heimstaedt-Muskett, Clarissa Masur
doi : 10.1111/jdv.18843
Primary axillary hyperhidrosis (PAHH) strongly affects the patient's quality of life. To date, topical treatment options are limited. One percent glycopyrronium bromide (GPB) showed promising efficacy and safety in a pivotal 4-week Phase 3a study.
DermARTologie/DermARTology. Carnation - Skin in the fine arts by Günter Burg, Michael Geiges, Cathérine Hug, Berlin-New York: Springer Nature. 2022. 239 pp. Price EUR 101.86. ISBN: 978–3–662-65,029-5. https://doi-org.focus.lib.kth.se/10.1007/978-3-662-65030-1
Johannes Ring
doi : 10.1111/jdv.18972
Tocilizumab in multisystem inflammatory syndrome in children (MIS-C)-summarized experiences
Man Man Niu, Qi Jiang, Yue Cao, Qian Yang, Yan Fang Zhang, Dao Ting Li, Peng Hu
doi : 10.1111/jdv.18784
Seroconversion and neutralizing antibodies production after completion of Pfizer-BioNTech BNT 162b2 vaccination scheme among psoriatic patients receiving biological or topical treatment: A prospective observational cohort study
Giuseppe Stinco, Enzo Errichetti, Matteo Figini, Alba Guglielmo, Benedetta Fazzi, Luca Quartuccio, Alen Zabotti, Salvatore De Vita, Miriam Isola, Maria De Martino, Silvia Rossi, Riccardo Lucis, Martina Fabris, Antonio Paolo Beltrami, Francesco Curcio, Federica D'Aurizio
doi : 10.1111/jdv.18809
New insights on acral peeling dermatoses: An overlooked skin manifestation during COVID-19 pandemic
Iria Neri, Alba Guglielmo, Annalucia Virdi, Miriam Leuzzi, Bianca Maria Piraccini, Marco Adriano Chessa
doi : 10.1111/jdv.18815
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals
Gianluca Avallone, Carlo Alberto Maronese, Claudio Conforti, Paolo Fava, Luigi Gargiulo, Angelo Valerio Marzano, Cesare Massone, Luca Mastorino, Andrea Paradisi, Alessandro Pileri, Pietro Quaglino, Nathalie Rizzo, Simone Ribero, Gabriele Roccuzzo, Gianluca Tavoletti, Carlo Alberto Vignoli, Iris Zalaudek, Emilio Berti, Silvia Alberti-Violetti
doi : 10.1111/jdv.18806
Epidermal necrolysis after COVID−19 vaccination: An exploratory analysis using World Health Organization VigiBase
Btisseme Ahouach, Emmanuelle Diaz, Blandine Bertin, Benoit Ben Said, Sandrine Combret, Aurélie Grandvuillemin, Nadine Petitpain, Marie Blanche Rabier, Laure Thomas, Thierry Trenque, Saskia Ingen-Housz-Oro, Bénédicte Lebrun-Vignes
doi : 10.1111/jdv.18845
Meek micrografting, a novel surgical technique for the treatment of vitiligo and piebaldism: A case series
Nicoline F. Post, Vidhya S. Narayan, Marcel W. Bekkenk, Albert Wolkerstorfer
doi : 10.1111/jdv.18829
Abdominoperineal necrotizing soft tissue infection: A single-centre retrospective study of 61 patients including short- and medium-term source of infection check
Margaux Mongereau, Camille Hua, Tomas Urbina, Paul Louis Woerther, Tiphaine Pelegrin, Nicola de'Angelis, Quentin De Roux, Romain Bosc, Barbara Hersant, Nicolas de Prost, Olivier Chosidow
doi : 10.1111/jdv.18729
Passive smoking and hidradenitis suppurativa: a retrospective analysis
Inês AparÃcio Martins, Clara Valente, Pedro Simões Farinha, Beatriz Figueira Vilela, Joana Cabete
doi : 10.1111/jdv.18702
Two paradoxical reactions in a patient with psoriasis and psoriatic arthritis: Adalimumab-induced hidradenitis suppurativa and secukinumab-induced alopecia areata
Neslihan Demirel Öğüt
doi : 10.1111/jdv.18601
A new universe in Dermatology: From metaverse to Dermoverse
Miriam Fernández-Parrado, Héctor Perandones-González
doi : 10.1111/jdv.18525
Prurigo pigmentosa (Nagashima disease) in bathing suit distribution mimicking contact dermatitis
Thilo Gambichler, Martin Doerler, Christina H. Scheel, Klara Bastek, Maria Chatzipantazi
doi : 10.1111/jdv.18607
TMeB score may improve risk stratification of high-risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study
Javier Cañueto, Luis Antonio Corchete-Sánchez, Chrysalyne D. Schmults, Natalia GarcÃÂa-Sancha, Roberto Corchado-Cobos, Marina Mendiburu-Eliçabe, ÃÂ�ngel Santos-Briz, Esther Cardeñoso-ÃÂ�lvarez, Jesús Pérez-Losada, Concepción Román-Curto, Emily S. Ruiz
doi : 10.1111/jdv.18775
Mogamulizumab-associated rash simulating lupus miliaris disseminatus faciei
Christina Mitteldorf, Norman Langer, Werner Kempf, Michael P. Schön
doi : 10.1111/jdv.18741
Store-and-forward mobile application as an accessible method of study participant assessment
Emily A. Cowen, Mary Daotung Sun, Lilly Gu, Christian Acevedo, Veronica Rotemberg, Allan C. Halpern
doi : 10.1111/jdv.18671
Palmoplantar keratoderma as a clinical feature of pathogenic variants in the filaggrin gene
Julia M. K. Clabbers, Marieke C. Bolling, Charlotte Burms, Maaike Vreeburg, Henny H. Lemmink, Peter C. van den Akker, Peter M. Steijlen, Michel van Geel, Antoni H. Gostyński
doi : 10.1111/jdv.18699
Further insights into the wider impact of childhood atopic dermatitis – Comment on “Burden of childhood atopic dermatitis on parents: Fathers' and mothers' respective feelings� by Mahé et al.
Pavel V. Chernyshov, Lucia Tomas-Aragones, Dennis Linder, Anthony Bewley, Carmen Maria Salavastru, Servando E. Marron, Liana Manolache, Nives Pustisek, Andrea W. M. Evers, Dimitra Koumaki, Damiano Abeni, Alina Suru, Sam S. Salek, Andrew Y. Finlay
doi : 10.1111/jdv.18687
Erythrodermic atopic dermatitis resistant to dupilumab and baricitinib successfully treated with upadacitinib
Clara Valente, Bruno Duarte
doi : 10.1111/jdv.18714
Simplified lower eyelid reconstruction algorithm after basal cell carcinoma surgery: A retrospective series of patients
Pedro Redondo, Jesús Barrio, Rafael Salido-Vallejo, Alejandra Tomás-Velázquez
doi : 10.1111/jdv.18712
Retrospective study correlating the clinical outcome of alopecia areata with specific prognostic factors
Michela Starace, Aurora Maria Alessandrini, Val Constantine S. Cua, Federico Francesco Cucinotta, Francesca Bruni, Matilde Iorizzo, Bianca Maria Piraccini
doi : 10.1111/jdv.18748
Long-term stability of PASI <3 response to tildrakizumab: Pooled analyses from reSURFACE 1 and reSURFACE 2 phase 3 trials through 5 years
Diamant Thaçi, Stefano Piaserico, Kristian Gaarn Du Jardin, Richard B. Warren
doi : 10.1111/jdv.18783
Quality and consistency of clinical practice guidelines for the local management of anogenital warts: A systematic review using AGREE II score and RIGHT checklist
Elisa Joly, Anissa Desmoulin, Phuong-Lien Tran, Christian Derancourt, Antoine Bertolotti
doi : 10.1111/jdv.18828
Two cases of Hallopeau-type pemphigus vegetans with anti-desmoglein 1 and anti-desmocollin 3 antibodies without mucosal involvement
Takuya Kawamura, Ken Muramatsu, Akihiro Orita, Yosuke Mai, Tatsuro Sugai, Naoya Haga, Yu Fujimura, Toshinari Miyauchi, Kentaro Izumi, Hiroshi Koga, Norito Ishii, Hideyuki Ujiie
doi : 10.1111/jdv.18704
Tolerance and efficacy of a spray containing Rhealba oat plantlets and Uncaria tomentosa extracts in reducing symptoms of herpes zoster
Adam Reich, Jacek C. Szepietowski, Sophie Baradat, Marie Dominique Thouvenin, Fabienne Carballido
doi : 10.1111/jdv.18740
Comparison of performance of SCORTEN, ABCD-10 and Re-SCORTEN in a cohort of patients with Stevens–Johnson syndrome/toxic epidermal necrolysis
Tyng-Shiuan Hsieh, Tom C. Chan, Yung-Tsu Cho, Chia-Yu Chu
doi : 10.1111/jdv.18734
Long-term secukinumab efficacy in patients with moderate to severe hidradenitis suppurativa: A retrospective single-centre case series (23 patients)
Francisco Javier Melgosa Ramos, Ramón GarcÃÂa Ruiz, Andrea Estébanez Corrales, Almudena Mateu Puchades
doi : 10.1111/jdv.18685
The alopecia areata donut sign. Evidence of synchronous hair growth in adult humans
Leila Asfour, Leslie N. Jones, Rodney D. Sinclair
doi : 10.1111/jdv.18754
Monkeypox with exclusive genital lesions
Joanna Maj, Kamila Wala, Jacek C. Szepietowski
doi : 10.1111/jdv.18621
A novel EVER1 gene mutation associated with epidermodysplasia verruciformis and multiple cutaneous malignancies
Na Young Kim, Dong-Uk Cheon, Hae Chang Joh, Jeong Eun Kim
doi : 10.1111/jdv.18682
Increasing to weekly adalimumab dosing leads to improved psoriasis outcomes�A retrospective single-centre review of real-world data
Amaani B. Hussain, Alison Havelin, Stephanie Ball, Sophie Weatherhead, Nick J. Reynolds, Philip Hampton
doi : 10.1111/jdv.18623
Mast cell protease/protease-activated receptor-2 axis: Another mechanism of pigmentation in cutaneous lesions of mastocytosis
Takashi Hashimoto, Manami Okuzawa, Satoshi Okuno, Takahiro Satoh
doi : 10.1111/jdv.18823
Improvement of the attitude of students to persons with skin diseases after a single presentation of patients' stories: A pilot study
Pavel V. Chernyshov, Kamila Wala, Ewa Wójcik, Jacek С. Szepietowski
doi : 10.1111/jdv.18744
Mortality in eight autoimmune bullous diseases: A global large-scale retrospective cohort study
Katharina Boch, Henner Zirpel, Diamant Thaci, Noor Mruwat, Detlef Zillikens, Ralf J. Ludwig, Khalaf Kridin
doi : 10.1111/jdv.18700
Systemic inflammatory trunk recurrent acute macular eruption (SITRAME): A new auto-inflammatory syndrome in adult?
Angèle Soria, Emmanuelle Amsler, Bethsabée Garel, Philippe Moguelet, Nathalie Tieulié, Florence Cordoliani, Isabelle Guichard, Antoine Mahé, Gilles Grateau, Guilaine Boursier, Sophie Georgin-Lavialle
doi : 10.1111/jdv.18771
Short-term real-world experience with baricitinib treatment in Danish adults with moderate–severe atopic dermatitis
Ida Vittrup, Jesper Elberling, Lone Skov, Kristina Sophie Ibler, Gregor B. E. Jemec, Charlotte G. Mortz, Rasmus Overgaard Bach, Carsten Bindslev-Jensen, Maiken Glud Dalager, Alexander Egeberg, Maria Kamstrup, Mette Deleuran, Christian Vestergaard, Jacob P. Thyssen
doi : 10.1111/jdv.18804
Dichotomic response patterns to PD-1 blockade with cemiplimab in a patient with multiple squamous cell carcinomas
Giulia Bazzacco, Enrico Zelin, Ludovica Toffoli, Claudio Conforti, Nicola di Meo, Dahlia Fedele, Iris Zalaudek
doi : 10.1111/jdv.18705
Pigmented genital lesions: A prospective cross-sectional study
Chloé David-Ferreira, Estelle Ravni, Céline Bourgea, Elisa Cinotti, Linda Tognetti, Jean-Luc Perrot, François Skowron
doi : 10.1111/jdv.18821
Maculopapular rash: An overlooked monkeypox diagnostic clue?
Gianluca Avallone, Carlo Alberto Maronese, Eleonora Quattri, Gabriele Roccuzzo, Luca Mastorino, Silvia Alberti-Violetti, Stefano Ramoni, Anna Lucchini, Sergio Delmonte, Pietro Quaglino, Angelo Valerio Marzano, Simone Ribero
doi : 10.1111/jdv.18695
Treatment of chronic hand eczema with dupilumab�A retrospective follow-up study
Caroline Meyer Olesen, Yasemin Topal Yüksel, Claus Zachariae, Tamara Theresia Lund, Tove Agner, Tonny Studsgaard Petersen, Jacob Pontoppidan Thyssen
doi : 10.1111/jdv.18805
Dermatoscopic features in monkeypox
Francisco J. RodrÃguez-Cuadrado, Marta Elosua-González, Gaston Roustan-Gullón, Fernando Alfageme-Roldán
doi : 10.1111/jdv.18650
Scoring hidradenitis suppurativa: How to simplify data collection?
Mathieu Daoud, Farida Benhadou, Hassane Njimi, Gregor B. E. Jemec, Mathilde Daxhelet, Jonathan White, Stéphanie Heudens, Jalila Karama, Mariano Suppa, Veronique del Marmol
doi : 10.1111/jdv.18707
Melanocytes in idiopathic guttate hypomelanosis disappear and are senescent
Tae Hyung Kim, Hyoungsoo Park, Du Jin Baek, Hee Young Kang
doi : 10.1111/jdv.18757
